Healthcare Value Capital as of Sept. 30, 2019
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 18 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 26.8 | $15M | 50k | 296.78 | |
| Gilead Sciences (GILD) | 13.7 | $7.6M | 120k | 63.38 | |
| GlaxoSmithKline | 7.7 | $4.3M | 100k | 42.68 | |
| Proshares Tr Ii Vix Strmfut Et etfeqty | 7.0 | $3.9M | 200k | 19.52 | |
| Abbvie (ABBV) | 6.8 | $3.8M | 50k | 75.72 | |
| CVS Caremark Corporation (CVS) | 5.7 | $3.2M | 50k | 63.08 | |
| Walgreen Boots Alliance (WBA) | 5.0 | $2.8M | 50k | 55.32 | |
| Tyme Technologies | 4.9 | $2.7M | 2.3M | 1.19 | |
| Viking Therapeutics (VKTX) | 3.1 | $1.7M | 250k | 6.88 | |
| Cardinal Health (CAH) | 3.0 | $1.7M | 35k | 47.20 | |
| AmerisourceBergen (COR) | 3.0 | $1.6M | 20k | 82.35 | |
| McKesson Corporation (MCK) | 2.5 | $1.4M | 10k | 136.70 | |
| Antares Pharma | 2.4 | $1.3M | 400k | 3.34 | |
| Adamas Pharmaceuticals | 1.9 | $1.0M | 200k | 5.12 | |
| Noveliontherapeuti.. | 1.8 | $1.0M | 1.4M | 0.72 | |
| Clovis Oncology | 1.8 | $983k | 250k | 3.93 | |
| Foamix Pharmaceuticals | 1.6 | $912k | 300k | 3.04 | |
| Greenlane Holdings Cl A Ord | 1.2 | $678k | 200k | 3.39 |
